Drug-eluting bead transarterial chemoembolization (TACE) exhibits superior efficacy and equal tolerance to conventional TACE in hepatocellular carcinoma patients with conventional TACE history
Clinics and Research in Hepatology and Gastroenterology(2022)
Abstract
•DEB-TACE achieves better short-term efficacy compared to cTACE.•HCC patients received DEB-TACE reaches longer survival profile than cTACE.•DEB-TACE (vs. cTACE) independently correlates with prolonged PFS and OS.•DEB-TACE displays similar safety profile as cTACE in treating HCC patients.
MoreTranslated text
Key words
Hepatocellular carcinoma,Conventional transarterial chemoembolization,Drug-eluting bead transarterial chemoembolization,Efficacy,Safety
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined